Identification of candidate genes that mediate depressive side effects of pegylated IFN-α2a in patients with chronic hepatitis C
M Trippler, Y Erim, S Bein, G Gerken, JF Schlaak · Zeitschrift für Gastroenterologie · 2007 · Heft 01
Bibliografische Angaben
Zusammenfassung
Aims and background: Combination therapy with pegylated interferon IFN-α plus ribavirin has been shown to be the most effective treatment for chronic hepatitis C (HCV). One of the most common side effects is IFN-induced severe depression, which can impair quality of life, reduce treatment adherence and even lead to suicide. Therefore, defining relevant risk factors for IFN-α induced depression is essential for designing preventative treatment strategies. This study assessed the primary transcriptional response to IFN-α2a plus ribavirin in HCV patients to identify possible candidate genes that mediate the depress…